Country - Portugal
Summary - Direct Adjustment For Acquisition Of B770 - Bevacizumab [25 Mg/Ml; 100 Mg/ 4 Ml; Conc For Sol For Infusion; Flasks] Patients Undergoing Treatment And T1592 - Tocilizumab [162 Mg/ 0.9 Ml; Pen].
Deadline - login to view
MT reference number - 95273898
Product classification - Pharmaceutical products
Address - Portugal
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 95273898
Document Type - Tender Notices
Description - Description: Direct adjustment for acquisition of B770 and T1592Direct adjustment for acquisition of B770 - Bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc for sol for infusion; pen] patients undergoing treatment and T1592 - Tocilizumab [162 mg/ 0.9 ml; pe n].notice_title: Direct Adjustment For Acquisition Of B770 - Bevacizumab [25 Mg/Ml; 100 Mg/ 4 Ml; Conc For Sol For Infusion; Flasks] Patients Undergoing Treatment And T1592 - Tocilizumab [162 Mg/ 0.9 Ml; Pen].local description: : Ajuste direto para aquisição de B770 e T1592Ajuste direto para aquisição de B770 - Bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc p/a sol p/a perfusão; frs] doentes em tratamento e T1592 - Tocilizumab [162 mg/ 0.9 ml; ca
Mt Ref Id - 95273898
Deadline - Nov 30, -0001
Similar Tenders :
Healthcare and Medicine